| # | Drug | Count |
|---|---|---|
| 0 | CYCLOPHOSPHAMIDE | 8 |
| 1 | CYCLOPHOSPHAMIDE FOR INJECTION | 8 |
| 2 | CYCLOPHOSPHAMIDE INJECTION, SOLUTION | 8 |
| 3 | NATALIZUMAB | 7 |
| 4 | ESOMEPRAZOLE MAGNESIUM | 6 |
| 5 | FLUOXETINE HYDROCHLORIDE | 6 |
| 6 | PREDNISONE | 6 |
| 7 | ADALIMUMAB | 5 |
| 8 | CARBOPLATIN | 4 |
| 9 | DIMETHYL FUMARATE | 4 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | LEVOKETOCONAZOLE | 3 | 0.0040 |
| 1 | SELADELPAR LYSINE | 1 | 0.0036 |
| 2 | MECASERMIN | 2 | 0.0025 |
| 3 | LARONIDASE | 3 | 0.0007 |
| 4 | ISAVUCONAZONIUM SULFATE | 2 | 0.0005 |
| 5 | VELAGLUCERASE ALFA | 1 | 0.0005 |
| 6 | LOMUSTINE | 1 | 0.0004 |
| 7 | NUSINERSEN | 3 | 0.0004 |
| 8 | ACETAZOLAMIDE SODIUM | 2 | 0.0003 |
| 9 | ZIPRASIDONE | 1 | 0.0003 |
| # | Drug class | Count |
|---|---|---|
| 0 | Alkylating Drug [EPC] | 9 |
| 1 | Corticosteroid [EPC] | 9 |
| 2 | Integrin Receptor Antagonist [EPC] | 8 |
| 3 | Benzodiazepine [EPC] | 7 |
| 4 | GLP-1 Receptor Agonist [EPC] | 6 |
| 5 | Nonsteroidal Anti-inflammatory Drug [EPC] | 6 |
| 6 | Aldosterone Antagonist [EPC] | 4 |
| 7 | Insulin Analog [EPC] | 4 |
| 8 | Interferon beta [EPC] | 4 |
| 9 | Microtubule Inhibitor [EPC] | 4 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Cortisol Synthesis Inhibitor [EPC] | 3 | 0.0040 |
| 1 | Antisense Oligonucleotide [EPC] | 3 | 0.0003 |
| 2 | Hydrolytic Lysosomal Glycosaminoglycan-specific Enzyme [EPC] | 3 | 0.0002 |
| 3 | Calcitonin Gene-related Peptide Receptor Antagonist [EPC] | 1 | 0.0001 |
| 4 | Hydrolytic Lysosomal Glucocerebroside-specific Enzyme [EPC] | 1 | 0.0001 |
| 5 | Carbonic Anhydrase Inhibitor [EPC] | 2 | 0.0001 |
| 6 | Human Immunoglobulin G [EPC] | 2 | 0.0001 |
| 7 | Sympathomimetic-like Agent [EPC] | 3 | 0.0001 |
| 8 | Integrin Receptor Antagonist [EPC] | 8 | 0.0001 |
| 9 | Recombinant Human Growth Hormone [EPC] | 2 | 0.0001 |